NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 8985 | WLN: 1R D-I-R D1 &E &6/14 | 0.0137891122538509 | -0.072487155 |
NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.013789112253851 | -0.26427464 |
NSC 23925 | Null | 0.013789112253851 | -0.33585214 |
NSC 321491 | Null | 0.013789112253851 | 0.32865072 |
NSC 34757 | Melicopidine | 0.013789112253851 | -0.12013893 |
NSC 638409 | (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide | 0.013789112253851 | -0.17855194 |
NSC 649664 | Null | 0.013789112253851 | -0.13798099 |
NSC 129518 | Cyclopyrethrosin | 0.0171490505199911 | -0.062002976 |
NSC 176324 | 5-Isoxazoleacetic acid, .alpha.-amino-3-chloro-4,5-dihydro-4-hydroxy-, (4R-(4.alpha.,5.beta.(S*)))- | 0.0171490505199911 | -0.18494207 |
NSC 201863 | N-[1-(Biphenyl-4-yl)ethyl]-3,4-dichlorobenzamide | 0.0171490505199911 | 0.50422544 |